Hip dysplasia, Beukes type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2114OMIM:142669Q65.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hip dysplasia, Beukes type (also known as Beukes familial hip dysplasia or coxarthrosis) is a rare inherited skeletal disorder first described in a large Afrikaner family in South Africa. The condition primarily affects the hip joints, leading to progressive premature degenerative arthritis (osteoarthritis) of the hips. It is caused by a pathogenic variant in the UFSP2 gene on chromosome 4q35, which encodes a protease involved in the UFM1 ubiquitin-like modification pathway. The disease typically manifests in early childhood, with affected individuals developing hip dysplasia characterized by flattening and irregularity of the femoral heads (the ball portion of the hip joint). Over time, this leads to progressive joint degeneration, pain, and significant limitation of hip mobility. The condition appears to be largely confined to the hip joints, distinguishing it from more generalized skeletal dysplasias, although mild changes in other joints have occasionally been noted. Radiographic findings include fragmentation and flattening of the femoral capital epiphyses, resembling Legg-Calvé-Perthes disease, but occurring bilaterally and with a clear hereditary pattern. There is currently no cure or disease-specific treatment for Beukes type hip dysplasia. Management is symptomatic and supportive, focusing on pain relief, physical therapy to maintain mobility, and orthopedic interventions. Many affected individuals ultimately require total hip replacement surgery due to severe degenerative changes. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of bone mineral densityHP:0004348Broad femoral neckHP:0006429Abnormal ossification involving the femoral head and neckHP:0009107Abnormality of the epiphysis of the femoral headHP:0010574Abnormal bone ossificationHP:0011849
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hip dysplasia, Beukes type.

View clinical trials →

No actively recruiting trials found for Hip dysplasia, Beukes type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hip dysplasia, Beukes type community →

No specialists are currently listed for Hip dysplasia, Beukes type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hip dysplasia, Beukes type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hip dysplasia, Beukes typeForum →

No community posts yet. Be the first to share your experience with Hip dysplasia, Beukes type.

Start the conversation →

Latest news about Hip dysplasia, Beukes type

No recent news articles for Hip dysplasia, Beukes type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hip dysplasia, Beukes type

What is Hip dysplasia, Beukes type?

Hip dysplasia, Beukes type (also known as Beukes familial hip dysplasia or coxarthrosis) is a rare inherited skeletal disorder first described in a large Afrikaner family in South Africa. The condition primarily affects the hip joints, leading to progressive premature degenerative arthritis (osteoarthritis) of the hips. It is caused by a pathogenic variant in the UFSP2 gene on chromosome 4q35, which encodes a protease involved in the UFM1 ubiquitin-like modification pathway. The disease typically manifests in early childhood, with affected individuals developing hip dysplasia characterized by

How is Hip dysplasia, Beukes type inherited?

Hip dysplasia, Beukes type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hip dysplasia, Beukes type typically begin?

Typical onset of Hip dysplasia, Beukes type is childhood. Age of onset can vary across affected individuals.